Live Breaking News & Updates on Jakob Lindberg

Stay updated with breaking news from Jakob lindberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Oncopeptides enters into a renewed loan facility agreement of up to €30 million with the European Investment Bank

/PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat. ....

United Kingdom , Rolf Gulliksen , Jakob Lindberg , European Union , Global Head Of Corporate Communications , European Investment Bank , Nasdaq Stockholm , European Economic Area , Global Head , Corporate Communications , Peptide Drug Candidate , Marketing Authorization , Mid Cap , European Investment ,

Oncopeptides enters into a renewed loan facility agreement of up to €30 million with the European Investment Bank

/PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat. ....

United Kingdom , Rolf Gulliksen , Jakob Lindberg , European Union , Global Head Of Corporate Communications , European Investment Bank , Nasdaq Stockholm , European Economic Area , Global Head , Corporate Communications , Peptide Drug Candidate , Marketing Authorization , Mid Cap , European Investment , Oncopeptides Ab ,

Oncopeptides enters into a renewed loan facility agreement of up to €30 million with the European Investment Bank

/PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat. ....

United Kingdom , Rolf Gulliksen , Jakob Lindberg , European Union , Global Head Of Corporate Communications , European Investment Bank , Nasdaq Stockholm , European Economic Area , Global Head , Corporate Communications , Peptide Drug Candidate , Marketing Authorization , Mid Cap , European Investment ,

Oncopeptides publishes Q3 report 2022

/PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat. ....

United Kingdom , Annika Muskantor , Rolf Gulliksen , Jakob Lindberg , Sweden Innovation Agency , Oncologic Drugs Advisory Committee , European Union , European Commission , Global Head Of Corporate Communications , Nasdaq Stockholm , General Meeting , Drugs Advisory Committee , Innovation Agency , Chief Executive Officer Jakob Lindberg , Chief Commercial Officer Sofia Heigis , Chief Financial Officer Annika , Global Head , Corporate Communications , Swedish Financial Instruments Trading Act , Peptide Drug Candidate , Marketing Authorization , European Economic Area , Mid Cap , Oncopeptides Ab ,

Oncopeptides announces the market potential for Pepaxti in Europe

/PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat. ....

Jakob Lindberg , European Union , European Medicines Agency , European Commission , Global Head Of Corporate Communications , Nasdaq Stockholm , Marketing Authorization , European Economic Area , Corporate Communications , Peptide Drug Candidate , Mid Cap , Oncopeptides Ab ,